Bayer | BAYN - Operating Profit

Stock Price
39.70
Daily Change
-0.43 -1.06%
Monthly
3.62%
Yearly
86.67%
Q2 Forecast
38.53

Bayer reported EUR1.11B in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Air Liquide EUR 2.84B 6.65B Dec/2025
Akzo Nobel EUR 217M 80M Dec/2025
Alcon AG USD 313M 19M Dec/2025
Amarin USD -2.26M 564K Dec/2025
Arkema EUR 25M 82M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
BASF EUR -175M 668M Dec/2025
Bayer EUR 1.11B 1.65B Dec/2025
Beiersdorf EUR 504M 312M Dec/2025
Corteva USD 811M 1.08B Dec/2025
Covestro EUR -324M 5.72B Dec/2025
Essilor EUR 1.38B 626M Dec/2025
Fresenius EUR 713M 139M Dec/2025
Fresenius Medical Care EUR 663M 213.06M Dec/2025
Genmab DKK 260M 199M Dec/2025
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 275.38M 76.74M Dec/2025
Henkel EUR 1.42B 187M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Johnson Matthey GBP 142M 89M Dec/2025
Linde USD 2.25B 160M Dec/2025
Lonza CHF 673M 243M Jun/2025
Merck EUR 474M 738M Dec/2025
Novartis USD 4.06B 437M Dec/2025
Nutrien USD 704M 88M Dec/2025
Philips EUR 719M 390M Dec/2025
PPG Industries USD 450M 128M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
SAP EUR 2.78B 1.95B Dec/2025
Solvay EUR 60M 78M Dec/2025
UCB EUR 1.29B 571M Dec/2025
Umicore EUR 304.3M 959.85M Jun/2025
Vinci EUR 6.05B 2.25B Dec/2025